4//SEC Filing
Jenkins John Kenneth 4
Accession 0001209191-21-041462
CIK 0001595097other
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 4:43 PM ET
Size
7.9 KB
Accession
0001209191-21-041462
Insider Transaction Report
Form 4
Jenkins John Kenneth
Director
Transactions
- Award
Stock Option (right to buy)
2021-06-17+58,200→ 58,200 totalExercise: $2.07Exp: 2031-06-17→ Common Stock (58,200 underlying) - Award
Stock Option (right to buy)
2021-06-17+58,200→ 58,200 totalExercise: $2.07Exp: 2031-06-17→ Common Stock (58,200 underlying)
Footnotes (2)
- [F1]The annual option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. The option will vest in equal monthly installments over the course of 12 months beginning on the date of grant.
- [F2]Represents a special retention award comprised of options to purchase common stock. The option will vest in equal monthly installments over the course of 12 months beginning on the date of grant.
Documents
Issuer
Corbus Pharmaceuticals Holdings, Inc.
CIK 0001595097
Entity typeother
Related Parties
1- filerCIK 0001742557
Filing Metadata
- Form type
- 4
- Filed
- Jun 16, 8:00 PM ET
- Accepted
- Jun 17, 4:43 PM ET
- Size
- 7.9 KB